Veterinary Medicines

Versican Plus DP lyophilisate and solvent for suspension for injection for dogs

Authorised
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine distemper virus, strain CDV Bio 11/A, Live
Download as PDF

Product identification

Medicine name:
Versican Plus DP lyophilisate and solvent for suspension for injection for dogs
Versican Plus DP Liofilizat (żywy, atenuowany):-Wirus nosówki psów, szczep CDV Bio 11/A ≥10^3,1 TCID50*, ≤10^5,1 TCID50,-Parwowirus psów, typ 2b, szczep CPV-2b-Bio 12/B ≥10^4,3 TCID50*, ≤10^6,6 TCID50.(*) Dawka zakaźna dla 50 % hodowli tkankowych Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine distemper virus, strain CDV Bio 11/A, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    19952.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain CDV Bio 11/A, Live
    1258.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:
  • (ID2) 50 Dose; 50 millilitre(s): Box (plastics) with 50 Vial (glass) each with 1 Dose and 50 Vial (glass) each with 1 millilitre(s)
  • (ID1) 25 Dose; 25 millilitre(s): Box (plastics) with 25 Vial (glass) each with 1 Dose and 25 Vial (glass) each with 1 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2570
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0266/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

2613562-paren-20251101.pdf

English (PDF)
Published on: 27/11/2025
Download